Logo image of MTAL

MAC COPPER LTD (MTAL) Stock Fundamental Analysis

NYSE:MTAL - JE00BQBC8469 - Common Stock

12.16 USD
0 (0%)
Last: 9/5/2025, 8:04:01 PM
12.16 USD
0 (0%)
After Hours: 9/5/2025, 8:04:01 PM
Fundamental Rating

3

MTAL gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 156 industry peers in the Metals & Mining industry. Both the profitability and financial health of MTAL have multiple concerns. MTAL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

MTAL had negative earnings in the past year.
MTAL had a positive operating cash flow in the past year.
In the past 5 years MTAL reported 4 times negative net income.
In the past 5 years MTAL reported 4 times negative operating cash flow.
MTAL Yearly Net Income VS EBIT VS OCF VS FCFMTAL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

MTAL has a worse Return On Assets (-5.80%) than 62.82% of its industry peers.
MTAL's Return On Equity of -14.71% is on the low side compared to the rest of the industry. MTAL is outperformed by 65.38% of its industry peers.
MTAL's Return On Invested Capital of 5.00% is fine compared to the rest of the industry. MTAL outperforms 63.46% of its industry peers.
Industry RankSector Rank
ROA -5.8%
ROE -14.71%
ROIC 5%
ROA(3y)-6.21%
ROA(5y)N/A
ROE(3y)-23.53%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MTAL Yearly ROA, ROE, ROICMTAL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -10 -20 -30 -40 -50

1.3 Margins

The Operating Margin of MTAL (22.68%) is better than 74.36% of its industry peers.
MTAL's Gross Margin of 31.07% is fine compared to the rest of the industry. MTAL outperforms 69.87% of its industry peers.
Industry RankSector Rank
OM 22.68%
PM (TTM) N/A
GM 31.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MTAL Yearly Profit, Operating, Gross MarginsMTAL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MTAL is destroying value.
MTAL has more shares outstanding than it did 1 year ago.
The debt/assets ratio for MTAL has been reduced compared to a year ago.
MTAL Yearly Shares OutstandingMTAL Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
MTAL Yearly Total Debt VS Total AssetsMTAL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 500M 1B

2.2 Solvency

MTAL has an Altman-Z score of 0.90. This is a bad value and indicates that MTAL is not financially healthy and even has some risk of bankruptcy.
MTAL has a worse Altman-Z score (0.90) than 78.85% of its industry peers.
The Debt to FCF ratio of MTAL is 7.34, which is on the high side as it means it would take MTAL, 7.34 years of fcf income to pay off all of its debts.
MTAL's Debt to FCF ratio of 7.34 is fine compared to the rest of the industry. MTAL outperforms 66.03% of its industry peers.
A Debt/Equity ratio of 0.63 indicates that MTAL is somewhat dependend on debt financing.
MTAL has a worse Debt to Equity ratio (0.63) than 79.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 7.34
Altman-Z 0.9
ROIC/WACC0.45
WACC11.01%
MTAL Yearly LT Debt VS Equity VS FCFMTAL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 1.12 indicates that MTAL should not have too much problems paying its short term obligations.
MTAL has a Current ratio of 1.12. This is amonst the worse of the industry: MTAL underperforms 80.77% of its industry peers.
MTAL has a Quick Ratio of 1.12. This is a bad value and indicates that MTAL is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.97, MTAL is doing worse than 71.79% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.97
MTAL Yearly Current Assets VS Current LiabilitesMTAL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 65.56% over the past year.
MTAL shows a strong growth in Revenue. In the last year, the Revenue has grown by 114.30%.
EPS 1Y (TTM)65.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.56%
Revenue 1Y (TTM)114.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%114.3%

3.2 Future

MTAL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 89.23% yearly.
The Revenue is expected to grow by 12.12% on average over the next years. This is quite good.
EPS Next Y453.57%
EPS Next 2Y167.26%
EPS Next 3Y104.94%
EPS Next 5Y89.23%
Revenue Next Year6.43%
Revenue Next 2Y15.2%
Revenue Next 3Y12.29%
Revenue Next 5Y12.12%

3.3 Evolution

MTAL Yearly Revenue VS EstimatesMTAL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
MTAL Yearly EPS VS EstimatesMTAL Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 0 1 -1 2

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

MTAL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 18.06, the valuation of MTAL can be described as rather expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as MTAL.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.69, MTAL is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 18.06
MTAL Price Earnings VS Forward Price EarningsMTAL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

82.05% of the companies in the same industry are more expensive than MTAL, based on the Enterprise Value to EBITDA ratio.
84.62% of the companies in the same industry are more expensive than MTAL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.8
EV/EBITDA 8
MTAL Per share dataMTAL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

MTAL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MTAL's earnings are expected to grow with 104.94% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y167.26%
EPS Next 3Y104.94%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MTAL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAC COPPER LTD

NYSE:MTAL (9/5/2025, 8:04:01 PM)

After market: 12.16 0 (0%)

12.16

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-23 2025-07-23/amc
Earnings (Next)10-20 2025-10-20/bmo
Inst Owners32.56%
Inst Owner Change178.72%
Ins Owners0.31%
Ins Owner ChangeN/A
Market Cap1.00B
Analysts77.78
Price Target15.24 (25.33%)
Short Float %2.01%
Short Ratio1.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-0.38%
EPS NY rev (3m)9.09%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 18.06
P/S 2.94
P/FCF 17.8
P/OCF 8.59
P/B 1.81
P/tB 1.81
EV/EBITDA 8
EPS(TTM)-0.99
EYN/A
EPS(NY)0.67
Fwd EY5.54%
FCF(TTM)0.68
FCFY5.62%
OCF(TTM)1.42
OCFY11.64%
SpS4.13
BVpS6.74
TBVpS6.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.8%
ROE -14.71%
ROCE 6.33%
ROIC 5%
ROICexc 5.82%
ROICexgc 5.82%
OM 22.68%
PM (TTM) N/A
GM 31.07%
FCFM 16.53%
ROA(3y)-6.21%
ROA(5y)N/A
ROE(3y)-23.53%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 7.34
Debt/EBITDA 2.25
Cap/Depr 77.1%
Cap/Sales 17.73%
Interest Coverage 1.64
Cash Conversion 75.01%
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 0.97
Altman-Z 0.9
F-Score7
WACC11.01%
ROIC/WACC0.45
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.56%
EPS Next Y453.57%
EPS Next 2Y167.26%
EPS Next 3Y104.94%
EPS Next 5Y89.23%
Revenue 1Y (TTM)114.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%114.3%
Revenue Next Year6.43%
Revenue Next 2Y15.2%
Revenue Next 3Y12.29%
Revenue Next 5Y12.12%
EBIT growth 1Y660.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year135.16%
EBIT Next 3Y50.95%
EBIT Next 5Y38.1%
FCF growth 1Y252.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1097.17%
OCF growth 3YN/A
OCF growth 5YN/A